Highly doubt it is sold through SAS. An only in class drug for OSA won’t be cheap nor should it.
Epydilox (sorry if I have misspelt) was thousands per treatment I believe before it was out on PBS.
Also the reason they go through FDA pathway, so government is picking up the tab.
Also means huge margin.
- Forums
- ASX - By Stock
- IHL
- Ann: IHL-42X phase 2 clinical trial presentation
Ann: IHL-42X phase 2 clinical trial presentation, page-26
-
- There are more pages in this discussion • 86 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)